Latest Headlines

Latest Headlines

GSK allows Brits to cut H1N1 vax order by one-third

GlaxoSmithKline has agreed that the British government can cut its order of H1N1 swine flu vaccines by about a third to 34.8 million doses, which includes the doses already delivered; the deal is

GSK will provide free vaccines for low-income Americans

GlaxoSmithKline has decided to make a direct contribution for improving the poor vaccination rates in U.S. adults. The pharma giant has created a new program that provides free shots against

GSK to give free adult vaccines to uninsured

GlaxoSmithKline has launched a vaccines access program that will provide shots--including the human papillomavirus preventive Cervarix--free of charge to low-income adults who don't have insurance

GSK, Pfizer discount vaccines for poor

Over the next 10 years, kids in developing countries will see a stream of discounted vaccines from Pfizer and GlaxoSmithKline. The two drugmakers have inked a long-term vaccine deal with the GAVI

WHO suspends Indian vax purchases as it probes quality

Perplexed by the appearance of mysterious white sediment inside vials of vaccine produced by an Indian subsidiary of Sanofi-Aventis, the World Health Organization has suspended the purchase and

Supremes agree to take vaccines case

The U.S. Supreme Court has agreed to hear a suit pitting parents against vaccine makers. The case would determine whether federal law protects vaccine makers from liability lawsuits in state court.

Vaccine reverses Parkinson's disease in animal study

An experimental vaccine being studied at the University of Nebraska Medical Center successfully spurred the development of dopamine-producing nerve cells, reversing Parkinson's disease in mice. And

Older women unlikely to benefit from HPV vax

A new study concludes that women over the age of 40 are unlikely to benefit from an HPV vaccine. Researchers tracked the experiences of 9,000 Costa Rican women ages 19 to 97 years, screening them for

Lancet editor on autism study: "We (all) really messed up."

Since The Lancet's recent decision to formally retract the controversial study connecting autism and childhood vaccines, there has been endless discussion about the enormous long-term fallout from

Lancet retracts controversial autism study

Twelve years ago, Dr. Andrew Wakefield published a study in the Lancet that linked autism with childhood vaccines, triggering an explosive controversy that continues to influence public opinion about